Donald C. Goff, MD | Psychiatrist.com

Original Research

Independent Effects of Tobacco Abstinence and Bupropion on Cognitive Function in Schizophrenia

September 15, 2005

A. Eden Evins, Thilo Deckersbach, Corinne Cather, et al

Original Research

Clozapine, Diabetes Mellitus, Hyperlipidemia, and Cardiovascular Risks and Mortality: Results of a 10-Year Naturalistic Study

September 15, 2005

David C. Henderson, Dana D. Nguyen, Paul M. Copeland, et al

Original Research

Medical Morbidity and Mortality in Schizophrenia: Guidelines for Psychiatrists

February 15, 2005

Donald C. Goff, Corinne Cather, A. Eden Evins, et al

Original Research

Attitudes of Schizophrenia Outpatients Toward Psychiatric Medications: Relationship to Clinical Variables and Insight

October 15, 2004

Oliver Freudenreich, Corinne Cather, A. Eden Evins, et al

Original Research

Two-Year Follow-Up of a Smoking Cessation Trial in Patients With Schizophrenia: Increased Rates of Smoking Cessation and Reduction.

March 1, 2004

A. Eden Evins, Corinne Cather, Nancy A. Rigotti, et al

Letter to the Editor

Polypharmacy in Schizophrenia: A Fuzzy Concept

September 1, 2003

Oliver Freudenreich, Donald C. Goff

Original Research

Risperidone Added to Clozapine: Impact on Serum Prolactin Levels

August 1, 2001

David C. Henderson, Donald C. Goff, Christine E. Connolly, et al

Letter to the Editor

Colon Perforation and Peritonitis Associated With Clozapine

December 31, 2000

Oliver Freudenreich, Donald C. Goff

Original Research

Switching From Clozapine to Olanzapine in Treatment-Refractory Schizophrenia: Safety, Clinical Efficacy, and Predictors of Response

November 15, 1998

David C. Henderson, Rima A. Nasrallah, Donald C. Goff

« 1 2